25.06.2024
Publications category: Conference
25.06.2024
A workflow for evaluating and optimizing the designs of paediatric studies
25.06.2024
Population pharmacokinetic-pharmacodynamic analysis of elafibranor and metabolite GFT1007 to support exposure-response characterization and dose selection in patients with primary biliary cholangitis
25.06.2024
Development of a PBPK model to predict monoclonal antibody pharmacokinetics and bioavailability following subcutaneous administration
25.06.2024
Physiologically-based pharmacokinetic (PBPK) modeling to predict disease effects on 5-flucytosine pharmacokinetics (PK) in the context of a switch from an immediate release (IR) to a sustained release (SR) formulation.
25.06.2024
A Physiologically Based Pharmacokinetic Model of Atorvastatin Acid Predicting CYP3A4 and OATP1B Drug–Drug Interactions
25.06.2024
The reference corrected VPC – A more intuitive model diagnostic
25.06.2024
Model-informed early clinical development of BI-1808, a novel monoclonal antibody to tumor necrosis factor receptor 2
25.06.2024
Generating uncertainty estimates in empirical forest plots
25.06.2024
Optimal design of a reduced sampling schedule for the characterization of prolactin dynamics in healthy male volunteers and its evaluation to the describe the pharmacodynamic effect of a prolactin antagonist in a single rising dose study
25.06.2024